• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAXTER HEALTHCARE CORPORATION CLEARLINK PACLITAXEL SETS; SET, ADMINISTRATION, INTRAVASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAXTER HEALTHCARE CORPORATION CLEARLINK PACLITAXEL SETS; SET, ADMINISTRATION, INTRAVASCULAR Back to Search Results
Catalog Number 2R8858
Device Problems Break (1069); Fluid/Blood Leak (1250); Protective Measures Problem (3015)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 02/13/2024
Event Type  malfunction  
Event Description
It was reported that a clearlink, paclitaxel set leaked from "one of the splices" (pump segment/bushing); there was a small opening in the spliced area.This was identified during patient infusion with taxol on an unspecified pump.The issue was further described as, "the taxol starting spraying out of the spliced area above the clamp" and the pumped alarmed an air in line alarm.A new set was used to continue treatment and a spill kit used to clean up the leak.The nurse was exposed to the medication on their hands; however, the nurse washed their hands with no further issues noted.There was no report of patient injury or medical intervention associated with this event.No additional information is available.
 
Manufacturer Narrative
G1: device manufacturer address 1: (b)(6).Should additional relevant information become available, a supplemental report will be submitted.
 
Manufacturer Narrative
Additional information was added to d4, h3, h4, and h6.The actual device was not available; however, a companion sample was received for evaluation.Visual inspection did not identify any abnormalities that could have contributed to the reported condition.The components are correctly placed and according to specifications.Functional testing included pressure testing, clear passage underwater testing, priming, and pull testing, and no defects were observed that could generate a leak.The reported condition was not verified.A batch review was conducted and there were no deviations found related to this reported condition during the manufacture of this lot.Should additional relevant information become available, a supplemental report will be submitted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CLEARLINK PACLITAXEL SETS
Type of Device
SET, ADMINISTRATION, INTRAVASCULAR
Manufacturer (Section D)
BAXTER HEALTHCARE CORPORATION
deerfield IL
Manufacturer (Section G)
BAXTER HEALTHCARE - CARTAGO
see h10
see h10
cartago 30106
CS   30106
Manufacturer Contact
25212 w. illinois route 120
round lake, IL 60073
2242702068
MDR Report Key18904637
MDR Text Key337685839
Report Number1416980-2024-01130
Device Sequence Number1
Product Code FPA
UDI-Device Identifier00085412565774
UDI-Public(01)00085412565774
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K160007
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 04/11/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/14/2024
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number2R8858
Device Lot NumberR23K01109
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received04/10/2024
Was Device Evaluated by Manufacturer? No
Date Device Manufactured11/02/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
TAXOL; UNSPECIFIED PUMP
-
-